Solar 18 Corporation (SLRN)
May 21, 2025 - SLRN was delisted (reason: merged into ALMS)
2.250
-0.020 (-0.88%)
Inactive · Last trade price on May 21, 2025

Theseus Pharmaceuticals Revenue

In the year 2005, Acelyrin had annual revenue of $250.00M.

Revenue (ttm)
$250.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
83
Market Cap
n/a

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2005250.00M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.